These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30267289)

  • 1. ASO Author Reflections: Central Lymph Node Status in the cN0 Tall-Cell Variant of Papillary Thyroid Cancer Deserves Further Attention in Clinical Practice.
    Shi X; Wang YL; Ji QH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):888-889. PubMed ID: 30267289
    [No Abstract]   [Full Text] [Related]  

  • 2. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
    Huang H; Xu Z; Wang X; Wu Y; Liu S
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
    Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
    Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of carbon nanoparticles in the lymph node biopsy of cN0 papillary thyroid carcinoma: A randomized controlled clinical trial.
    Xu XF; Gu J
    Asian J Surg; 2017 Sep; 40(5):345-349. PubMed ID: 26783035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
    Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
    Tulchinsky M
    Clin Nucl Med; 2018 Aug; 43(8):630. PubMed ID: 29742606
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
    Seo M; Kim YS; Lee JC; Han MW; Kim ES; Kim KB; Park SH
    Clin Nucl Med; 2018 Aug; 43(8):635-636. PubMed ID: 29517547
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
    Piccardo A; Giovanella L
    Clin Nucl Med; 2018 Aug; 43(8):631-632. PubMed ID: 29485434
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
    Seo M; Kim YS; Lee JC; Han MW; Kim ES; Kim KB; Park SH
    Clin Nucl Med; 2018 Aug; 43(8):633-634. PubMed ID: 29538034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors of central neck lymph node metastasis in cN0 papillary thyroid carcinoma].
    Zhang AB; Liu LF; Lu C; Ma YY; Dong YB; Ge XY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1141-1145. PubMed ID: 29798345
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of lymph node dissection in the VI area of cN0 thyroid papillary carcinoma].
    Dai W; Jiang B; Chen W; Han L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(4):319-21. PubMed ID: 27373042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
    Yan B; Hou Y; Chen D; He J; Jiang Y
    Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of central lymph node dissection in surgical treatment of papillary thyroid carcinoma].
    Chen Z; Dong H; Ye Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):120-2. PubMed ID: 25989657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.
    Gorshtein A; Benbassat C; Robenshtok E; Shimon I; Hirsch D
    World J Surg; 2016 Sep; 40(9):2123-30. PubMed ID: 27094559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research strategy for cN0 thyroid papillary carcinoma central lymph node dissection].
    Gong YP; Gong RX; Zhu JQ; Huang QS; Chen R; Li ZH; Wei T; Zou XH; Zhu XX
    Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1081-4. PubMed ID: 24499716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic prediction of BRAF(V600E) and its relationship with sodium iodide symporter in classic variant of papillary thyroid carcinomas.
    Gao WL; Wie LL; Chao YG; Wie L; Song TL
    Clin Lab; 2012; 58(9-10):919-26. PubMed ID: 23163107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.